Cargando…
The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex
PURPOSE: Our aim is to describe the role of immune checkpoint inhibitors (ICI) in clinical practice by providing the patient and tumor characteristics as well as survival and toxicity rates by sex. METHODS: We used electronic health records to identify patients treated at the Cancer Center of the Un...
Autores principales: | Wahli, Murielle N., Hayoz, Stefanie, Hoch, Dennis, Ryser, Christoph O., Hoffmann, Michèle, Scherz, Amina, Schwacha-Eipper, Birgit, Häfliger, Simon, Wampfler, Julian, Berger, Martin D., Novak, Urban, Özdemir, Berna C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314838/ https://www.ncbi.nlm.nih.gov/pubmed/35997822 http://dx.doi.org/10.1007/s00432-022-04309-2 |
Ejemplares similares
-
Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma—A Real World Single-Center Analysis
por: Hoffmann, Michèle, et al.
Publicado: (2022) -
Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease
por: Liu, Michael, et al.
Publicado: (2023) -
The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook
por: Tran, Linh Chi, et al.
Publicado: (2023) -
Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology
por: Özdemir, Berna C
Publicado: (2021) -
A Checkpoint-Related Function of the MCM Replicative Helicase Is Required to Avert Accumulation of RNA:DNA Hybrids during S-phase and Ensuing DSBs during G2/M
por: Vijayraghavan, Sriram, et al.
Publicado: (2016)